The Gross Margin of Cara Therapeutics Inc (CARA) is 91.31%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 91.31% |
| 2023-12-31 | 70.56% |
| 2022-12-31 | 82.58% |
| 2021-12-31 | -700.00% |